Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Colby

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 21, 2024
Incidence of symptomatic Lyme borreliosis in nine European countriesFrederick J Angulo, Emily Colby, Anne-Mette Lebech, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2023
Comprehensive Profile of Pathogens and Antimicrobial Resistance in Conjunctivitis Cases from NigerAbdou Amza, Beido Nassirou, Boubacar Kadri, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2025
Costs, Coverage, and Acceptability of Azithromycin Mass Administration to Children 1-11 Versus 1-59 Months Old to Reduce Mortality: A Cluster-Randomized Trial in NigerAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
BMJ Paediatrics Open|December 11, 2025
Impact of biannual azithromycin on weight-for-age z-score among infants in the AVENIR cluster-randomised trialBrittany Peterson, Ahmed Arzika, Ramatou Maliki, et al.
BMC Public Health|April 30, 2021
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)Kieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
BMJ Open|March 27, 2025
Mass distribution of azithromycin and child mortality among underweight infants in rural Niger: a subgroup analysis of the AVENIR cluster-randomised trialBrittany Peterson, Ahmed Arzika, Ramatou Maliki, et al.
Journal of Global Health|May 22, 2026
Predictors of home- vs. facility-based delivery among women living in rural Niger: a cross-sectional survey within the AVENIR cluster-randomised trialBrittany Peterson, Ahmed M Arzika, Ramatou Maliki, et al.
The New England Journal of Medicine|August 21, 2024
Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized TrialKieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 21, 2024
Incidence of symptomatic Lyme borreliosis in nine European countriesFrederick J Angulo, Emily Colby, Anne-Mette Lebech, et al.
PLOS Global Public Health|November 15, 2023
Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trialAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
The American Journal of Tropical Medicine and Hygiene|November 6, 2023
Comprehensive Profile of Pathogens and Antimicrobial Resistance in Conjunctivitis Cases from NigerAbdou Amza, Beido Nassirou, Boubacar Kadri, et al.
The American Journal of Tropical Medicine and Hygiene|April 8, 2025
Costs, Coverage, and Acceptability of Azithromycin Mass Administration to Children 1-11 Versus 1-59 Months Old to Reduce Mortality: A Cluster-Randomized Trial in NigerAhmed M Arzika, Ramatou Maliki, Abdou Amza, et al.
BMJ Paediatrics Open|December 11, 2025
Impact of biannual azithromycin on weight-for-age z-score among infants in the AVENIR cluster-randomised trialBrittany Peterson, Ahmed Arzika, Ramatou Maliki, et al.
BMC Public Health|April 30, 2021
Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)Kieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
BMJ Open|March 27, 2025
Mass distribution of azithromycin and child mortality among underweight infants in rural Niger: a subgroup analysis of the AVENIR cluster-randomised trialBrittany Peterson, Ahmed Arzika, Ramatou Maliki, et al.
Journal of Global Health|May 22, 2026
Predictors of home- vs. facility-based delivery among women living in rural Niger: a cross-sectional survey within the AVENIR cluster-randomised trialBrittany Peterson, Ahmed M Arzika, Ramatou Maliki, et al.
The New England Journal of Medicine|August 21, 2024
Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized TrialKieran S O'Brien, Ahmed M Arzika, Abdou Amza, et al.
Pageof 2